Long-term follow-up for heart attack survivors
Long-Term Follow-Up in Patients With Acute Myocardial Infarction Cohort - a Prospective, Multicenter Study
This study checks in with heart attack survivors a few years after their hospital stay to see how they’re doing with their health and medications.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 15000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Harbin Medical University Academic / other |
| Locations | 18 sites (Beijing, Beijing Municipality and 17 other locations) |
| Trial ID | NCT05862103 on ClinicalTrials.gov |
What this trial studies
This observational study follows up with survivors of acute myocardial infarction (AMI) who previously participated in a myocardial protection project. Participants will be contacted by telephone at 3 and 5 years post-discharge to gather information on their medication, health status, and any major adverse cardiovascular or cerebrovascular events. The study aims to assess long-term outcomes and the effectiveness of treatment strategies in this population.
Who should consider this trial
Good fit: Ideal candidates are AMI survivors who completed a 1-year follow-up visit as part of a previous myocardial protection project.
Not a fit: Patients who did not participate in the initial project or those who have not survived the first year post-AMI may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide valuable insights into the long-term health and treatment needs of AMI survivors.
How similar studies have performed: While similar long-term follow-up studies have been conducted, this specific approach focusing on AMI survivors and their treatment outcomes is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * AMI survivors who participated in the project "Construction and key technology research of the whole myocardial protection system for acute myocardial infarction" and completed the 1-year visit. * Telephone to obtain informed consent from the subjects/family members of the subjects. Exclusion Criteria: * Not available
Where this trial is running
Beijing, Beijing Municipality and 17 other locations
- Beijing An Zhen Hospital, Capital Medical University — Beijing, Beijing Municipality, China (Recruiting)
- Beijing Chao-Yang Hospital, Capital Medical University — Beijing, Beijing Municipality, China (Recruiting)
- Peking University First Hospital — Beijing, Beijing Municipality, China (Not_yet_recruiting)
- Guangdong general hospital — Guangzhou, Guangdong, China (Recruiting)
- The first affiliated hospital of Guangxi medical university — Nanning, Guangxi, China (Recruiting)
- Second hospital of hebei medical university — Shijiazhuang, Hebei, China (Recruiting)
- Daqing Oil Field Hospital — Daqing, Heilongjiang, China (Recruiting)
- The First Affiliated Hospital of Zhengzhou University — Zhengzhou, Henan, China (Recruiting)
- Zhongda Hospital Southeast University — Nanjing, Jiangsu, China (Recruiting)
- The Second Affiliated Hospital of Nanchang University — Nanchang, Jiangxi, China (Recruiting)
- The Second Hospital of Jilin University — Changchun, Jilin, China (Recruiting)
- The econd Affiliated Hospital of Dalian Medical University — Dalian, Liaoning, China (Recruiting)
- General Hospital of Northern Theater Command of the Chinese People's Liberation Army — Shenyang, Liaoning, China (Recruiting)
- Xijing Hospital of Air Force Military Medical University — Xi’an, Shanxi, China (Recruiting)
- Xinqiao Hospital Army Medical University — Chongqing, Sichuan, China (Recruiting)
- The General Hospital of Tianjin Medical University — Tianjin, Tianjin Municipality, China (Recruiting)
- Tianjin Chest Hospital — Tianjin, Tianjin Municipality, China (Recruiting)
- First Affiliated Hospital of Xinjiang Medical University — Ürümqi, Xinjiang, China (Recruiting)
Study contacts
- Study coordinator: Xiling Zhang, MD
- Email: xlzhangdr@163.com
- Phone: +86 13804608748
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.